Davide Ruggero, PhD et al published 
"Translation control of the immune checkpoint in cancer and its therapeutic targeting" in Nature Medicine.
Explains UCSF.edu's Nicoletta Lanesse, their "surprising new approach" hobbles deadly liver cancer by stifling protein production.
Click here to read full article...